What's Hot

View all perspectives
      RT @KDAO2011: Interestingly, anti-IFN Ab can be present in #SLE pts and impact the IFN signature.

      There is a bimodal t

      TheDaoIndex KDAO2011

      2 years 5 months ago
      Interestingly, anti-IFN Ab can be present in #SLE pts and impact the IFN signature. There is a bimodal type I IFN signature in #SLE. IFN and Blys signatures overlap (?distinct populations/interactions between the two?) - Prof T Dorner #EULAR2022 @rheumnow https://t.co/phLXv2KVxR
      RT @AurelieRheumo: All the domains of sexual sphere are deteriorated in RA and PsA.
      This aspect is often overlooked and

      Aurelie Najm AurelieRheumo

      2 years 5 months ago
      All the domains of sexual sphere are deteriorated in RA and PsA. This aspect is often overlooked and can have a significant impact on pts QoL. It may be time to assess this aspect more specifically using CSFQ-14 and propose dedicated interventions. #OP0139 @RheumNow #EULAR2022 https://t.co/l0zyBIZ1LI
      RT @RichardPAConway: Dr Puja Khanna. Transdermal sodium bicarbonate for gout flare. WHAT!? It works as well! Double-blin

      Richard Conway RichardPAConway

      2 years 5 months ago
      Dr Puja Khanna. Transdermal sodium bicarbonate for gout flare. WHAT!? It works as well! Double-blind RCT. All got colchicine also. Response rate 95% vs 79%. Resolution in 24 vs 72 hrs. Rescue meds 6% vs 20%. No adverse events! @RheumNow #EULAR2022 OP0170 https://t.co/INd4tMFVlV https://t.co/EyVjFLF72z
      RT @ericdeinmd: #EULAR2022 ASAS/EULAR AxSpA Recs
      ⭐️Last: 2016
      ▶️All: education, exercise, 🚭
      ▶️❌csDMARD

      Eric Dein ericdeinmd

      2 years 5 months ago
      #EULAR2022 ASAS/EULAR AxSpA Recs ⭐️Last: 2016 ▶️All: education, exercise, 🚭 ▶️❌csDMARD for axial disease ▶️TNF/IL17 (or JAK) with high disease: ASDAS>/=2.1 ▶️Monoclonal TNF for uveitis/IBD, high PsO: IL-17 ▶️Sustained remission: tapering of bDMARD "can be considered" @RheumNow https://t.co/3yYU0Vb37r
      RT @KDAO2011: Proof that MTX doesn't affect sperm! Sperm morphology, motility, concentration, semen volume, testosterone

      TheDaoIndex KDAO2011

      2 years 5 months ago
      Proof that MTX doesn't affect sperm! Sperm morphology, motility, concentration, semen volume, testosterone/LH/FSH similar b/f and after exposure; DNA fragmentat'n was⬆️in pre-MTX exposure (possible reason high dz activity contributes to infertility) #EULAR2022 @rheumnow OP0131 https://t.co/JWLEggRhAY
      RT @RichardPAConway: Hamroun @annamolto et al. Factors assoc with increased time to conception in SpA. 56 pregnancies. M

      Richard Conway RichardPAConway

      2 years 5 months ago
      Hamroun @annamolto et al. Factors assoc with increased time to conception in SpA. 56 pregnancies. Multivariate model, age (HR 1.22 (1.08-1.40)) and preconception NSAID use (HR 3.01 (2.15-3.85)) assoc increase time to conception. @RheumNow #EULAR2022 OP0153 https://t.co/y2EAyAdRmk https://t.co/28aLimRInE
      RT @KDAO2011: OP0129 Eudravigilance eval pregnancies exposed to non-TNF biologics compared certolizumab. Possible signal

      TheDaoIndex KDAO2011

      2 years 5 months ago
      OP0129 Eudravigilance eval pregnancies exposed to non-TNF biologics compared certolizumab. Possible signal w/#vendolizumab: 3 cases of corpus callosum agenesis (2 Crohn’s, 1 UC, 2 assc w/ other CNS malformations). Belim did not show consistent pattern #EULAR2022 @rheumnow https://t.co/BNKaxu6G0c
      RT @RichardPAConway: Perez-Garcia et al. MTX effect on semen parameters. I still frequently get queries about this. 48 p

      Richard Conway RichardPAConway

      2 years 5 months ago
      Perez-Garcia et al. MTX effect on semen parameters. I still frequently get queries about this. 48 participants here. No significant effect! @RheumNow #EULAR2022 OP0131 https://t.co/33NG6isehm https://t.co/g7Xn33i96u
      RT @Yuz6Yusof: #OP0142 #EULAR2022 Morand compared LLDAS in Early (<1yr) and Established #lupus. Although Early were

      Md Yuzaiful Md Yusof Yuz6Yusof

      2 years 5 months ago
      #OP0142 #EULAR2022 Morand compared LLDAS in Early (<1yr) and Established #lupus. Although Early were younger & had higher disease activity, time-to-LLDAS was shorter. LLDAS was protective of flare in both. Should target for LLDAS early in diagnosis to improve outcomes @RheumNow https://t.co/7i9c69YkR3
      RT @KDAO2011: In people without SLE who have severe COVID19 infection, autoAb against IFN-1 assc w/increased mortality P

      TheDaoIndex KDAO2011

      2 years 5 months ago
      In people without SLE who have severe COVID19 infection, autoAb against IFN-1 assc w/increased mortality Prof T Dorner #EULAR2022 @rheumnow https://t.co/nt2gACUtkL
      RT @RichardPAConway: BIOBADASER Registry data on comparative drug-dependent cancer risk in patients with prior cancer. 3

      Richard Conway RichardPAConway

      2 years 5 months ago
      BIOBADASER Registry data on comparative drug-dependent cancer risk in patients with prior cancer. 352 patients. 32 incident cancers (14 NMSC). No difference between agents, but wide CIs @RheumNow #EULAR2022 OP0138 https://t.co/NEZSL2AQhC https://t.co/EG0NflXXW6
      RT @RichardPAConway: Unizony et al. Case series of tocilizumab + 8 weeks steroid in GCA. 30 patients, 50% new 50% relaps

      Richard Conway RichardPAConway

      2 years 5 months ago
      Unizony et al. Case series of tocilizumab + 8 weeks steroid in GCA. 30 patients, 50% new 50% relapsing. 77% in sustained remission at week 52! No vision loss. Exciting, needs an RCT @RheumNow #EULAR2022 OP0185 https://t.co/ohBYIWYxBC https://t.co/fsn4x17Hwv
      RT @Janetbirdope: #Behcets. If topical oracort / steroids don’t work for Mucosal ulcers consider topical #tacrolimus

      Janet Pope Janetbirdope

      2 years 5 months ago
      #Behcets. If topical oracort / steroids don’t work for Mucosal ulcers consider topical #tacrolimus https://t.co/7ZiLfdwZoP
      RT @KDAO2011: New #SLE drug to pay attention to!
      iberdomide target Ikaros and Aiolos, reduce B cell, reduce autoAb and

      TheDaoIndex KDAO2011

      2 years 5 months ago
      New #SLE drug to pay attention to! iberdomide target Ikaros and Aiolos, reduce B cell, reduce autoAb and reduce IFN sig while enhancing regulatory T cells- Prof T Dorner #EULAR2022 @rheumnow https://t.co/q39pxK3gFJ
      RT @AurelieRheumo: Spanish safety registry BIOBADASER 3.0:
      *9000+ pts with IMID treated w/ bio or tsDMARDS
      *352 pts w/ p

      Aurelie Najm AurelieRheumo

      2 years 5 months ago
      Spanish safety registry BIOBADASER 3.0: *9000+ pts with IMID treated w/ bio or tsDMARDS *352 pts w/ prior malignancy *32 incident malignancies -> 27 events/1000PY NO diff between ttmts in incidence or mortality but low number pts in non TNFi groups @RheumNow #EULAR2022 OP0138 https://t.co/8IyC6NdGCF

      Podcasts

      • ACR24 - RHEUMATOID ARTHRITIS
      • ACR24 - IL - 17
      • ACR24 - JAK TYK2

      Catch up on Conference Podcasts

      Featured Video

      Do you get our email newsletter?

      Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

      Copyright {{ 'now'|date('Y') }} All Rights Reserved.